InsiderClue
Insiders · Profile

WINQUIST RAYMOND

Head, Translational Research at Xenon Pharmaceuticals. Filing since 18 Aug 2017. CIK 0001670668

Company
Date
Role
Action
Shares
Amount
Of holding
XENE Xenon Pharmaceuticals Inc.
18 Aug 2017
Head, Translational Research
Bought
1,000
$3.00K
opened
1 decision on file.